Etiquetas: Brain‑computer interface

Science Corp., led by former Neuralink president Max Hodda, is advancing brain‑computer interface technology through two main avenues. The company has refined the Prima retinal implant, originally acquired from Pixium Vision, and is completing clinical trials that show most patients regain functional reading ability. At the same time, Science Corp. is developing bio‑hybrid neural interfaces that grow engineered neurons on a wafer‑like device to augment brain function. Both efforts aim to create commercially viable medical products while laying groundwork for longer‑term goals such as optogenetic gene therapy and large‑scale neural augmentation. Leer más

Cognixion, a California‑based startup, announced a clinical trial that pairs its noninvasive brain‑computer interface (BCI) with Apple’s Vision Pro headset. The trial aims to enable people with paralysis‑related speech disorders to communicate using brain signals captured by a custom headband equipped with six EEG sensors. Up to ten U.S. participants with conditions such as spinal‑cord injury, stroke, traumatic brain injury, or ALS will test the system, which combines AI‑driven language models with visual fixation detection. Cognixion’s goal is to democratize BCI technology by offering a low‑risk, widely accessible solution. Leer más